US market weekly highlights for 6-10 September, 2021

Insider Observations We downgraded 4 stocks this past week, upgraded 6. We lead with this sentence because “4” is the most number of downgrades we have had for many weeks. Insider sentiment has been deteriorating but that shift hadn’t generated many downgrades until this past week. Insider trading volume has begun declining ahead of 3Q […]

Read More

$ESGR.US – Enstar Group Ltd ranked positive on September 9th, 2021

Robert Campbell (Enstar Group Chairman since 2011, joined in 2007) purchased $447,760 of stock on September 3rd at $223.88. Whilst this is a small addition to his holding of 163,306 shares, this purchase is notable as it is his largest and the highest price he has paid. It also represents a reversal from a timely […]

Read More

$3333.HK share price are now down over 34% due to funding concerns.

China Evergrande’s share price is under sustained pressure due to funding concerns. We originally negatively ranked the stock on the 4th August 2021 on the back of share sales by two directors. The shares are now down over 34% since we ranked it. This is what we said in our internal report in August: Qi He […]

Read More

$CANO US – Cano Health Inc ranked positive on 1 September 2021

Cano Health Inc – (CANO, +1, Sep 1st) Marlow Hernandez (CEO since 2009) purchased 1.576 million shares at a cost of $16.9 million in a series of stock buys during August 2021, at an average price of $10.73. As at the prospectus he owned 21.9 million Class B shares. Richard Aguilar (Chief Clinical Officer since […]

Read More

$ASAN US shares are now up over 100%

Asana announced record Q2 results last week resulting in strong share price performance. We originally positively ranked the stock on the 10th of June on buying from Dustin Moskovitz CEO and the shares are now up over 100% since we ranked it. This is what we said when we ranked the stock in June: Dustin […]

Read More

$VRTX.US – Vertex Pharmaceutical Inc ranked positive on August 24, 2021

Reshma Kewalramani (Vertex Pharmaceutical Inc CEO since 2020, joined 2018) purchased $2.0 million of stock on the 19th August at $195.65, increasing his holding by 16%. This is a notable trade as it is his first buy since joining the company and he has been a regular seller of options and stock via 10b5-1 program […]

Read More

US market weekly highlights for 31 August – 3 September, 2021

Insider Observations The pace of insider buying slowed this past week from 23rd to 27th August 2021, however insider sentiment remains neutral with five sells for every four buy trades. We reviewed far fewer interesting buys, likely a combination of higher stock prices (Russell 2000 +5% on the week, S&P 500 +1.5%), buyer fatigue, early […]

Read More

$PSN – Parsons Corp ranked positive on August 19, 2021

Parsons Corp – (PSN, +1, Aug 19th) George Ball (CFO since 2008) purchased $874,000 of stock on the 16th August at $34.95, increasing his holding by 14%. His 3 previous buys since the company’s IPO in May 2019 at $27 have been well timed, most recently buying at $30.25 in November 2020. His record at […]

Read More

US market weekly highlights for 23-27 August, 2021

Insider Observation Insiders (senior management and execs trading shares in their companies) in the U.S. are keeping us busy, especially those filling out the green order tickets. We upgraded 19 stocks where we see notable insider activity, with no downgrades. To come up with those 19 newly ranked stocks we analyzed approximately 150 insider purchases […]

Read More

US market weekly highlights for 16-20 August, 2021

It was a busy week for insider (senior management and execs trading shares in their companies) activity in the US, Insider Sentiment remained neutral with 1.4 Sells to every buy, we found far more interesting insider purchases than we did sales. We upgraded 18 stocks this week where we see notable insider activity. This is […]

Read More